Term Name: EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor
Synonyms: acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitor, acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitors, EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitors, EC 1.3.1.9 inhibitor, EC 1.3.1.9 inhibitors, enoyl-[acyl carrier protein] reductase inhibitor, enoyl-[acyl carrier protein] reductase inhibitors, enoyl-ACP reductase inhibitor, enoyl-ACP reductase inhibitors, ENR inhibitor, ENR inhibitors, NADH-enoyl acyl carrier protein reductase inhibitor, NADH-enoyl acyl carrier protein reductase inhibitors, NADH-specific enoyl-ACP reductase inhibitor, NADH-specific enoyl-ACP reductase inhibitors
Definition: An EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of enoyl-[acyl-carrier-protein] reductase (NADH), EC 1.3.1.9.
Ontology: ChEBI [CHEBI:139512]  ( EBI )

Relationships
is a type of: EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor
inverse has_role: atromentin triclosan